Provided by Tiger Trade Technology Pte. Ltd.

AEON Biopharma

0.2463
-0.0107-4.16%
Post-market: 0.2412-0.0051-2.07%18:56 EDT
Volume:1.46M
Turnover:350.52K
Market Cap:12.29M
PE:-0.07
High:0.2500
Open:0.2439
Low:0.2321
Close:0.2570
52wk High:1.45
52wk Low:0.1772
Shares:49.88M
Float Shares:30.51M
Volume Ratio:0.03
T/O Rate:4.79%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.5840
EPS(LYR):-3.9532
ROE:--
ROA:-141.53%
PB:-0.80
PE(LYR):-0.06

Loading ...

AEON Financial Service's Profit Jumps 35% in Fiscal 2026

MT Newswires Live
·
Apr 08

AEON Financial Service Sets 2030 Profit Targets and Asia-Focused Digital Finance Push

TIPRANKS
·
Apr 08

Aeon Financial Service Lifts Revenue, Warns of Profit Drop in FY2026 Outlook

TIPRANKS
·
Apr 08

AEON Moves to Fully Acquire Struggling Footwear Subsidiary GFOOT via Share Consolidation

TIPRANKS
·
Apr 08

AEON Fantasy Lifts Full-Year Profit Outlook on Record Sales and FX Gains Despite ASEAN Pressure

TIPRANKS
·
Apr 06

Aeon receives additional notice related to NYSE American listing standards

TIPRANKS
·
Apr 06

AEON Biopharma grants CFO John Bencich 1.0 million inducement equity awards

Reuters
·
Apr 04

AEON Biopharma Reports Inducement Grants Under NYSE American LLC Company Guide Section 711

GlobeNewswire
·
Apr 04

AEON Biopharma gets NYSE American notice for failing stockholders’ equity listing standard

Reuters
·
Apr 04

AEON Biopharma Receives Additional Notice Related to NYSE American Continued Listing Standards

GlobeNewswire
·
Apr 04

Aeon Credit Service Asia SEHK 900 Margin Compression Keeps Bearish Narratives Alive After FY 2026 Results

Simply Wall St.
·
Apr 01

AEON CREDIT Reports Fiscal Year Profit Surge to HK$468 Million

Stock News
·
Mar 31

AEON Credit Service (Asia) Declares Final Dividend for FY2025/26

TIPRANKS
·
Mar 31

AEON Biopharma Q4 EPS $(3.72)

Benzinga Earnings
·
Mar 31

AEON Biopharma FY25 net loss widens to $39 million

Reuters
·
Mar 31

Press Release: AEON Biopharma Reports Full Year 2025 Financial Results and Highlights Positive Comparative Analytical Results and FDA Feedback for ABP-450 Biosimilar Program

Dow Jones
·
Mar 31

AEON Stores Hong Kong to See Chairman and Non-Executive Director Retire at 2026 AGM

TIPRANKS
·
Mar 27

Aeon Biopharma announces FDA feedback after Type 2a meeting

TIPRANKS
·
Mar 25

AEON Biopharma Inc - to Request Bpd Type 2B Meeting With FDA in 2026 for Abp-450 Biosimilar

THOMSON REUTERS
·
Mar 25

AEON Biopharma Inc - FDA Supports AEON's Analytical Similarity Strategy Under 351(K) Biosimilar Pathway

THOMSON REUTERS
·
Mar 25